about
Neurotoxins: free radical mechanisms and melatonin protectionModerate alcohol consumption and 24-hour urinary levels of melatonin in postmenopausal womenThe dark side of light at night: physiological, epidemiological, and ecological consequencesTherapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapySleep duration and breast cancer phenotypeLight at night and breast cancer risk among California teachersInhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cellsMelatonin, an inhibitory agent in breast cancer.What is known about melatonin, chemotherapy and altered gene expression in breast cancerMelatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashesMelatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review).Urinary 6-sulfatoxymelatonin level and breast cancer risk: systematic review and meta-analysis.Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literatureShift work, hCLOCK T3111C polymorphism, and endometriosis risk.Scientific basis for the potential use of melatonin in bone diseases: osteoporosis and adolescent idiopathic scoliosis.Melatonin combats molecular terrorism at the mitochondrial level.Extended exposure to dietary melatonin reduces tumor number and size in aged male mice.Effect of melatonin on human dental papilla cells.Melatonin anticancer effects: reviewMolecularly imprinted electrochemical sensing of urinary melatonin in a microfluidic system.Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives.Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night.Melatonin: an inhibitor of breast cancer.A cross-sectional study of breast cancer biomarkers among shift working nurses.Protective effects of melatonin in experimental free radical-related ocular diseases.Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment.Protective effect of melatonin against Adriamycin-induced cardiotoxicity.Sleep duration, melatonin and breast cancer among Chinese women in Singapore.Epigenetic regulation: a new research area for melatonin?Nightshift work and fracture risk: the Nurses' Health Study.Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks.State of the evidence: the connection between breast cancer and the environment.Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer.Urinary melatonin levels and skin malignancy.Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implicationsFirst-morning urinary melatonin and breast cancer risk in the Guernsey StudyLight-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis.Melatonin and cancer: current knowledge and its application to oral cavity tumours.Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation.
P2860
Q22305781-9CB0AFCA-3B7B-446B-9F1B-6ACAEB0731D3Q23922166-63C1E133-87F1-4FD2-97ED-EFB935AB4D04Q28246097-46743C54-A653-4CFE-A6AF-6D50A19D4C55Q28266443-3F6EEDAA-0AD9-4BC1-AB04-E456B74CEF4DQ28391366-195750E3-0988-412F-B167-0A4C27172B52Q28392200-374D734C-18D7-4ABE-BA72-1873A599EB8AQ28580837-1E0607E7-696F-4CA9-A152-36621A5FDEB3Q30489143-41002F87-0DF0-48BF-B27B-13B09AA089A8Q33597963-CC1CB9E1-0E80-488C-945C-27AECA29B123Q33624824-F5C524C7-7DBA-4079-90FA-6B540DE3BD54Q33768639-8F4F3D01-1E0E-4269-B947-824E08567F41Q33844198-086DF506-ACD8-4FE2-B86B-268721C0732BQ33902985-00D4468D-9EFD-4483-998F-8BB10D59E4CAQ34042761-CE61F25C-1BD0-43C0-AC84-95D3FC53B99CQ34097100-A6BFD8CC-B04E-418E-9DFA-87CC2AA22A77Q34211436-31BAC05F-E539-4325-959D-ECDEAEED70DEQ34359618-03DEB7C8-1EDE-4732-B141-B91BF8FE51F8Q34388391-502B0423-D9A3-43CD-81DA-686AD603ACBCQ34486505-1462F269-9B79-48D6-91AE-E77A19E336F8Q34647628-8D2A382E-C434-4DF8-8919-CB46B6FA40C2Q34912724-0E5A2F54-0407-49E5-956A-196552237F46Q34994700-9D3BDB01-7DEF-4889-A648-7A40058F0B2FQ35181910-C3AC1F72-F585-4F3E-A1DB-54B00E3CBDD1Q35689110-E82515A4-FF09-41D1-A237-256CDDED059CQ35714716-E159B27A-052B-40C8-8814-5286B33C3FECQ36379509-91769CA1-2250-42B8-B6EC-28982C64AF36Q36872043-BBA890F7-95A1-4C44-B5A4-80D20CCDFD93Q36900610-179FEC10-1DDF-4D3A-980C-75BE78AC8BB6Q36951983-3DD58FCB-A66F-4ABE-B5B6-9695E02CB73FQ37031603-5E9E350B-C922-4608-AFF3-15CB30D8A3CAQ37119193-922F4500-7C6A-475E-96E3-EC8BFF8F7CB8Q37210222-FB4F7E5A-B7B3-44C5-A5EA-3021B40569CBQ37408121-CFD4BF35-DEAF-4070-B32F-31E8D0421A6FQ37458674-B236B32B-4766-46DB-A548-876DB3CF7400Q37494101-46CBD47A-38C3-4D8F-BD1C-434E6C291AAFQ37525906-BC3F9556-1C63-4018-9B01-A12127992C2EQ37591161-12FAA93F-F724-4281-A22C-F2C1743D2F0DQ37665036-E5AD585C-724A-476E-803E-24D5730F3CB8Q37834066-8F7ADDDB-0459-468A-919B-52697C5352AEQ38002452-37A6B1FB-E7C8-4FBC-B6EC-FD5239BA95D3
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Melatonin-estrogen interactions in breast cancer.
@ast
Melatonin-estrogen interactions in breast cancer.
@en
type
label
Melatonin-estrogen interactions in breast cancer.
@ast
Melatonin-estrogen interactions in breast cancer.
@en
prefLabel
Melatonin-estrogen interactions in breast cancer.
@ast
Melatonin-estrogen interactions in breast cancer.
@en
P50
P1476
Melatonin-estrogen interactions in breast cancer
@en
P2093
Alicia González
Dolores Mediavilla
P304
P356
10.1111/J.1600-079X.2004.00207.X
P577
2005-05-01T00:00:00Z